cp wire

CP Wire Articles

BeiGene Announces Acceptance of its NDA in China for Zanubrutinib in Certain Types of Leukemia and Lymphoma
  • Zanubrutinib demonstrated a high overall response rate of 80 percent
  • Zanubrutinib was recently granted Fast Track Designation by the US FDA for Waldenström macroglobulinemia (WM)... read more
Wed, 10/24/18 - 11:53 am
Stelara Shines in Three Year Crohn's Disease Study
  • 60.3% of all randomised ustekinumab-treated patients who entered the long-term extension study were in clinical remission at week 152
  • Of those patients who were naïve to TNF... read more
Wed, 10/24/18 - 09:45 am
Almac Diagnostic Services to Develop Companion Diagnostic for TP Therapeutics' Cancer Drug



TP Therapeutics announced on 10/24/18 a global collaboration agreement to develop and commercialize a next-generation sequencing (NGS) companion diagnostic (CDx) for repotrectinib, TP... read more

Wed, 10/24/18 - 09:30 am
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
  • Bain Capital committed $350 million to the company
  • Pfizer is contributing a portfolio of assets that includes three clinical-stage compounds


Bain Capital, LP and... read more

Tue, 10/23/18 - 10:14 am
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
  • OMS721 also has orphan status for two other conditions
  • OMS721 is Omeros’ lead human MASP-2 antibody
  • The drug was awarded fast track designation for the treatment of patients... read more
Tue, 10/23/18 - 09:43 am

Pages